{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:09:29Z","timestamp":1784603369883,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jinf.2020.09.025","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:01:54Z","timestamp":1600977714000},"page":"758-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection"],"prefix":"10.1016","volume":"81","author":[{"given":"Seth R","family":"Shaffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E","family":"Targownik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Smieliauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harminder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2020.09.025_bib0001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1056\/NEJM200002103420604","article-title":"Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A","volume":"342","author":"Kyne","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0002","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","author":"Lessa","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0003","unstructured":"Prevention CfDCa. 2017Annual report for the emerging infections program for clostridioides difficule infecetion, 2019."},{"key":"10.1016\/j.jinf.2020.09.025_bib0004","doi-asserted-by":"crossref","first-page":"ofv076","DOI":"10.1093\/ofid\/ofv076","article-title":"Incidence and costs of clostridium difficile infections in Canada","volume":"2","author":"Levy","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0005","doi-asserted-by":"crossref","first-page":"E758","DOI":"10.1503\/cmaj.180013","article-title":"The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015)","volume":"190","author":"Katz","year":"2018","journal-title":"CMAJ"},{"key":"10.1016\/j.jinf.2020.09.025_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jhin.2019.04.007","article-title":"Predictors of mortality and length of stay in patients with hospital-acquired Clostridioides difficile infection: a population-based study in Alberta, Canada","volume":"103","author":"Leal","year":"2019","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jinf.2020.09.025_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172410","article-title":"A population-based matched cohort study examining the mortality and costs of patients with community-onset Clostridium difficile infection identified using emergency department visits and hospital admissions","volume":"12","author":"Nanwa","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.09.025_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(18)31154-5","article-title":"Sa1073 - Time trends of laboratory confirmed clostridium difficile infections in an entire province suggest an increasing shift to community acquired infections and younger age of acquiring infections","volume":"154","author":"Nugent","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2020.09.025_bib0009","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2013more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0010","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1572-0241.2002.05839.x","article-title":"Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease","volume":"97","author":"McFarland","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0011","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/cid\/ciy149","article-title":"Clinical practice guidelines for clostridium difficile infection in adults and children: 2017 update by the infectious diseases society of America (IDSA) and society for healthcare epidemiology of America (SHEA)","volume":"66","author":"McDonald","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0012","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1056\/NEJMoa1205037","article-title":"Duodenal infusion of donor feces for recurrent Clostridium difficile","volume":"368","author":"van Nood","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0013","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.18098","article-title":"Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent clostridium difficile infection: a randomized clinical trial","volume":"315","author":"Lee","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2020.09.025_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170258","article-title":"Cost-effectiveness analysis of five competing strategies for the management of multiple recurrent community-onset clostridium difficile infection in France","volume":"12","author":"Baro","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.09.025_bib0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1017\/ice.2014.80","article-title":"Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection","volume":"36","author":"Varier","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0016","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/cid\/ciu128","article-title":"Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis","volume":"58","author":"Konijeti","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0017","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1111\/jgh.13402","article-title":"Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia","volume":"31","author":"Merlo","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0018","article-title":"Cost-effectiveness of treatment regimens for Clostridioides difficile infection -an evaluation of the 2018 Infectious Diseases Society of America guidelines","author":"Rajasingham","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0019","unstructured":"HERC: Cost-Effectiveness Analysis."},{"key":"10.1016\/j.jinf.2020.09.025_bib0020","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/ciy259","article-title":"Results from a randomized, placebo-controlled clinical Trial of a RBX2660-A microbiota-based drug for the prevention of recurrent clostridium difficile infection","volume":"67","author":"Dubberke","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0021","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/jama.2017.17077","article-title":"Effect of oral capsule- vs colonoscopy-delivered fecal microbiota transplantation on recurrent clostridium difficile infection: a randomized clinical trial","volume":"318","author":"Kao","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.jinf.2020.09.025_bib0022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205064","article-title":"Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: a randomized clinical trial","volume":"13","author":"Jiang","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.jinf.2020.09.025_bib0023","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/ajg.2017.6","article-title":"Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study","volume":"112","author":"Staley","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0024","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12916-016-0680-9","article-title":"Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection","volume":"14","author":"Youngster","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/19490976.2016.1273998","article-title":"Fecal microbiota transplant in severe and severe-complicated Clostridium difficile: a promising treatment approach","volume":"8","author":"Fischer","year":"2017","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jinf.2020.09.025_bib0026","unstructured":"Bank of Canada Inflation Calculator."},{"key":"10.1016\/j.jinf.2020.09.025_bib0027","unstructured":"CIHI. Patient Cost Estimator."},{"key":"10.1016\/j.jinf.2020.09.025_bib0028","unstructured":"Health Canada Guidance Document: Fecal Microbiota Therapy Used in the Treatment of Clostridium difficile Infection Not Responsive to Standard Therapies."},{"key":"10.1016\/j.jinf.2020.09.025_bib0029","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/cid\/civ994","article-title":"Establishing a fecal microbiota transplant service for the treatment of clostridium difficile infection","volume":"62","author":"Costello","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0030","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jval.2012.11.004","article-title":"Cost-effectiveness analysis evaluating fidaxomicin versus oral vancomycin for the treatment of Clostridium difficile infection in the United States","volume":"16","author":"Stranges","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.jinf.2020.09.025_bib0031","unstructured":"Global Burden of Disease Study 2017 (GBD 2017) Disability Weights."},{"key":"10.1016\/j.jinf.2020.09.025_bib0032","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/j.1365-2036.2008.03839.x","article-title":"A model of the long-term cost effectiveness of scheduled maintenance treatment with infliximab for moderate-to-severe ulcerative colitis","volume":"28","author":"Tsai","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2020.09.025_bib0033","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1472-6963-11-157","article-title":"Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine","volume":"11","author":"Prenzler","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jinf.2020.09.025_bib0034","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10198-009-0199-5","article-title":"Cost-effectiveness of infliximab for the treatment of acute exacerbations of ulcerative colitis","volume":"11","author":"Punekar","year":"2010","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jinf.2020.09.025_bib0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/j.1445-2197.2007.04226.x","article-title":"Is laparoscopic colectomy for cancer cost-effective relative to open colectomy?","volume":"77","author":"Hayes","year":"2007","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.jinf.2020.09.025_bib0036","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1046\/j.1525-1497.1998.00211.x","article-title":"Interpretation of cost-effectiveness analyses","volume":"13","author":"Owens","year":"1998","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0037","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1586\/14737167.8.2.165","article-title":"Assessing cost-effectiveness in healthcare: history of the $50,000 per QALY threshold","volume":"8","author":"Grosse","year":"2008","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jinf.2020.09.025_bib0038","unstructured":"OpenBiome."},{"key":"10.1016\/j.jinf.2020.09.025_bib0039","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/MCG.0000000000000494","article-title":"Cost averted with timely fecal microbiota transplantation in the management of recurrent clostridium difficile infection in Alberta, Canada","volume":"50","author":"Waye","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1086\/502023","article-title":"Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals","volume":"23","author":"Miller","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"Suppl 6","key":"10.1016\/j.jinf.2020.09.025_bib0041","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12064","article-title":"Consequences of Clostridium difficile infection: understanding the healthcare burden","volume":"18","author":"Bouza","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jinf.2020.09.025_bib0042","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/ng.2478","article-title":"Emergence and global spread of epidemic healthcare-associated Clostridium difficile","volume":"45","author":"He","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jinf.2020.09.025_bib0043","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1086\/678428","article-title":"Attributable inpatient costs of recurrent Clostridium difficile infections","volume":"35","author":"Dubberke","year":"2014","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0044","unstructured":"Tixier E.N., Verheyen E., Ungaro R.C., et\u00a0al. Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients. Aliment Pharmacol Ther;0."},{"key":"10.1016\/j.jinf.2020.09.025_bib0045","doi-asserted-by":"crossref","first-page":"487","DOI":"10.7326\/L15-5139","article-title":"Decrease in surgery for clostridium difficile infection after starting a program to transplant fecal microbiota","volume":"163","author":"Cammarota","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0046","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1056\/NEJMc1913670","article-title":"Donor screening for fecal microbiota transplantation","volume":"381","author":"Kassam","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0047","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1086\/501553","article-title":"Recurrent Clostridium difficile disease: epidemiology and clinical characteristics","volume":"20","author":"McFarland","year":"1999","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.jinf.2020.09.025_bib0048","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ajic.2015.06.004","article-title":"Impact of Clostridium difficile-associated diarrhea on acute care length of stay, hospital costs, and readmission: a multicenter retrospective study of inpatients, 2009-2011","volume":"43","author":"Magee","year":"2015","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.jinf.2020.09.025_bib0049","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jhin.2014.04.011","article-title":"Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review","volume":"88","author":"Gabriel","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jinf.2020.09.025_bib0050","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2019-319548","article-title":"International consensus conference on stool banking for faecal microbiota transplantation in clinical practice","author":"Cammarota","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jinf.2020.09.025_bib0051","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/cid\/cix529","article-title":"Vancomycin taper and pulse regimen with careful follow-up for patients with recurrent clostridium difficile infection","volume":"65","author":"Sirbu","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.jinf.2020.09.025_bib0052","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin","volume":"55","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0053","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.09.025_bib0054","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/apt.13144","article-title":"Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection","volume":"41","author":"Cammarota","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2020.09.025_bib0055","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/j.gastro.2018.12.019","article-title":"Fecal microbiota transplantation is superior to fidaxomicin for treatment of recurrent clostridium difficile infection","volume":"156","author":"Hvas","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jinf.2020.09.025_bib0056","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/cid\/civ938","article-title":"Safety and Durability of RBX2660 (Microbiota Suspension) for recurrent clostridium difficile infection: results of the PUNCH CD Study","volume":"62","author":"Orenstein","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0057","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/apt.13969","article-title":"Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy","volume":"45","author":"Jiang","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2020.09.025_bib0058","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/apt.13009","article-title":"Simple faecal preparation and efficacy of frozen inoculum in faecal microbiota transplantation for recurrent Clostridium difficile infection\u2013an observational cohort study","volume":"41","author":"Satokari","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jinf.2020.09.025_bib0059","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1007\/s10096-011-1522-5","article-title":"Hospital-acquired Clostridium difficile infection: determinants for severe disease","volume":"31","author":"Wenisch","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0060","first-page":"450","article-title":"Fulminant Clostridium difficile colitis","volume":"13","author":"Adams","year":"2007","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jinf.2020.09.025_bib0061","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/cid\/ciy715","article-title":"Outcomes of community and healthcare-onset clostridium difficile infections","volume":"68","author":"Mora Pinzon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2020.09.025_bib0062","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/00000658-200203000-00008","article-title":"Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications","volume":"235","author":"Dallal","year":"2002","journal-title":"Ann Surg"},{"key":"10.1016\/j.jinf.2020.09.025_bib0063","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1002\/bjs.8868","article-title":"Systematic review and meta-analysis of outcomes following emergency surgery for Clostridium difficile colitis","volume":"99","author":"Bhangu","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/j.jinf.2020.09.025_bib0064","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.sla.0000236628.79550.e5","article-title":"Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain","volume":"245","author":"Lamontagne","year":"2007","journal-title":"Ann Surg"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320306186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320306186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:31:15Z","timestamp":1759008675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320306186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S0163445320306186"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.09.025","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-effectiveness analysis of a fecal microbiota transplant center for treating recurrent C.difficile infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.09.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}